Health Archive » August, 2017

Health - August, 2017

350 articles

• Trump Slashes Spending On ACA Promos, Assistance
• 3 Catholic NJ Hospitals To Merge With Cooper Health Care
• HIV Org Wrongly Fired Worker Over Agreement: 2nd Circ.
• Aetna Faces Another Suit Over HIV Drug Info Disclosure
• NJ Paramedic Slaps Hospital With Whistleblower Suit
• Abortion Foe, Attys Hit With $195K Sanction For Videos
• Washington State AG Sues To Break Up Health Care System
• Med Board Right To Take Doctor's License, Texas Court Says
• In Bipartisan Push, 8 Governors Float ACA Fixes
• The Psychology Of Hourly Fee Arrangements
• Pfizer, Teva Among Latest Opioid Makers In Mo. Probe
• CareFirst And Constitutional Standing: A Post-Spokeo Review
• Home Health Clinicians Settle FLSA Suit In Arbitration
• Allied Can't Recoup $8M FTC Defense Costs, 9th Circ. Affirms
• Fed. Regs Can't Be Copyrighted, Nonprofit Tells DC Circ.
• Ex-UnitedHealth Unit VP, Fraud Pro Joins Nelson Hardiman
• 'Prior Good Acts' Not Allowed In Menendez Trial, Feds Say
• Amarin Calls For ITC Investigation Of Omega-3 Supplements
• FDA Issues Guidance On Real-World Medical Device Data
• 3rd Circ. Lipitor Ruling Smooths Way In Pay-For-Delay Suits
• Mars To Shed 12 Vet Clinics In FTC Deal Over $9.1B VCA Buy
• 3rd Circ. Overturns $1M Award In Suit Against Pa. Hospital
• FDA Announces Security Update For St. Jude Pacemakers
• Pa. Defense Atty Stopped Short In Abuse-Of-Process Claims
• Investing In Urgent Care: Trends And Developments To Watch
• Mattis Allows Transgender Troops To Serve During Review
• Real Estate Rumors: Memorial Sloan, Ritz-Carlton, Meadow
• Recent Settlements Suggest Off-Label Cases Aren't Extinct
• FDA Warning Wire: Stem Cell Clinic Fires Back
• Atty May Need DQ In Insys Bribery Case, Feds Say
• Real Estate Rumors: Village Foundation, NYC DOI, Centerline
• Hospital Laundry Co. Beats Ch. 11 Plan Challenge
• Insurer Says 4th Circ. Backs Coverage Denial Over Fake MD
• NLRB Used Wrong Supervisor Test, 3rd Circ. Says
• Surgeon Says Bone Drill Loud Enough To Damage Hearing
• Feds Say Shkreli Verdict Is No Escape For Ex-Katten Atty
• Miners Can't Sue Johns Hopkins Over Black Lung Benefits
• Nixed Class To Seek 7th Circ. Input On TCPA Fax Consent
• Express Scripts, Others Face ERISA Suit Over EpiPen Costs
• Advisory Board Inks $2.58B Health Care, Education Units Sale
• CVS Board Ignored Overbilling Scheme, Shareholder Suit Says
• Telehealth: A Priority For Advancing Quality Health Care
• Chinese National Charged In Trading OPM Hack Malware
• Couple Must Pay Back ACA Credits After Wife Gets Job
• EEOC Sues Ill. Co. For Firing Worker With Breast Cancer
• UNC Med School Forgoes No-Hires To Settle Antitrust Suit
• Aetna Hit With Class Action Over HIV Drug Disclosure
• Peekay Gets TRO Against Absent Credit Card Processing Firm
• Fired Kaiser Worker Loses Representation Suit Against Union
• Medical Co. In FCA Case Looks To Dodge Retaliation Claims
• Feds Must Act On Nursing Home Abuse, OIG Says
• Pa. Judge Won't Reverse Whistleblower's Kickback Win
• Escobar's Materiality Standard: Circuit Developments
• Self-Collection In E-Discovery — Risks Vs. Rewards
• Robinson Calcagnie, Smith Law Team Up To Take Down J&J
• Anthem's Record $115M Data Breach Deal Gets First Nod
• FCA Decision Tracker: Continued Interpretations Of Escobar
• Aetna's HIV Lapse Shows Snail Mail's Privacy Pitfalls
• Cohen Milstein OK'd To Re-Enter $360M Doctor Antitrust Suit
• Home Health Care Co. Wants US Atty DQ'd From Medicare Suit
• Ex-Judge Gets 4 Years In Social Security Fraud Case
• Trump Officially Reinstates Transgender Military Ban
• CVS Pharmacists Want To Add Plaintiff To Training Pay Suit
• Peekay Says Credit Card Processor Has Cut Off Services
• Steel Co. Supports $16M Medical Benefits Settlement
• Health Hires: Biopharma GCs, BigLaw Partners, US Prosecutor
• CVS Customers Drop Rx Clawback Suit, But Will Refile
• Examining FDA Reauthorization Act Add-On Provisions
• Menendez, Feds Clash Over Bid To Adjourn Trial For Votes
• Veteran's Suit Over Legionnaires' Disease Is Too Late
• EEOC Wellness Regs Ironically Join The Walking Dead
• 6 Common Lateral Partner Myths Debunked
• When A Firm Is 'Failing': CentraCare Vs. Energy Solutions
• Ex-Home Health Co. Partner Tells 9th Circ. $27M Verdict Fair
• BioScrip Investors Urge Del. Justices To Revive Lawsuit
• CBO Stresses Its 'Culture Of Objectivity' On ACA Repeal
• Cherokee Nation Wants Takeda Actos Suit To Stay In La.
• Real Estate Rumors: GPB, Amita Health, Rockpoint
• NJ Appeals Court Revives Patient Fall Suit Against ER Nurses
• Aetna Exposed Customers Taking HIV Meds, Legal Groups Say
• SEIU, Fight For $15 Launching Campaign For Pro-Worker Pols
• 8th Circ. Affirms Man's Verdict For Illegal Kickback Scheme
• 4 Ways Law Firms Can Help Battle Addiction
• Ark. Care Centers Dangerously Understaffed, Suit Claims
• Fresenius Seeks To Shed 10 More Suits From Dialysis MDL
• Jury Seated For Sen. Menendez Corruption Trial In NJ
• DOJ Vetoes $2.5M FCA Deal, Ends Up With Much Less
• A Law Firm Guide To Helping Victims Of Human Trafficking
• UK Watchdog Finds Health Merger Hurt Competition
• Doc In Hysterectomy Suit Can't Contest Award, 3rd Circ. Hears
• 3 Trial Losses Won't Doom Xarelto Patients
• Discovery Proportionality: A Defense View
• Science No Salve For J&J In Talc Cases, $417M Verdict Shows
• Jury Selection Kicks Off In Menendez Corruption Trial
• Fla. Doc Convicted Of Fraud Gets 1 Year And $3M In Fines
• SEC Tells Calif. Man To Hand Over $2.6M In EB-5 Proceeding
• Creditors Blast PE Firm's Release In Angelica Bankruptcy
• 1st Circ. Affirms Dismissal Of Sarepta Securities Suit
• 2nd Circ. Rebuffs Ex-Health Care Co. CFO's Fraud Appeal
• Ambry Aiming To Moot Suit Challenging $1B Konica Merger
• Fed. Circ. Says Medicare Settlement Case Correctly Moved
• Feds Net $12M From Eye Surgery Co. In FCA Kickbacks Deal
• 7th Circ. Upholds CMS Penalty In Nursing Home Abuse Case
• Meet The 'Horse Whisperer' Of ACA Policy
• UHC Ignoring Subpoena In Testosterone MDL, Endo Says
• AARP Gets Wellness Regs Kicked Back To EEOC
• Pharmacy Seeks Final OK For Roche's $17M TCPA Deal
• Schumaker Bungled Insolvency, Dental Network Co. Says
• Ex-Katten Atty Says Shkreli Verdict Nixes Conspiracy Count
• Diversity In The Legal Profession — A Stubborn Vision
• 11th Circ. Says Medicare Advantage Fight Not Ready For Court
• Why Midsize Firms Run The Gamut On Diversity
• Law Firms Head Back To School For Diversity Guidance
• States Ask High Court To Hear Florist's Same-Sex Objections
• CliniComp Sues Gov't Over Cerner's VA Contract
• GCs Find New Urgency In Longtime Push For Diversity
• Health System Socked With ERISA Suit Over Retirement Plans
• Investment Firm Settles SEC Inside Trading Row For $4.8M
• Insurer Accused Of Underpaying NJ Out-Of-Network Providers
• 3rd Circ. Revives Lipitor, Effexor Antitrust Claims
• NJ Surgeon's License Suspended Amid Sexual Abuse Charges
• 'Needling,' Not Refusal, Got Worker Fired, 2nd Circ. Hears
• Texas Justices Won't Hear Auto Policy Family Exclusion Row
• FDA Plans Forum On Opioid Cough Medicines For Children
• NJ Doc Sues Insurance Co., Attys For Malpractice In $1M Loss
• New Salary History Laws Crimp Attorney Hiring Process
• State And Local Tax Scoreboard: 2017 Midyear Review
• J&J Hit With $417M Verdict In 1st Calif. Talc Cancer Trial
• Calif. High Court Raises Conflict Issues For Public Entities
• The Top Employment Cases Of 2017, So Far
• The Best Firms For Minority Attorneys
• How 5 Firms Are Building More Diverse Ranks
• Racial Diversity Stagnating At US Law Firms
• The Top Firms For Minority Equity Partners
• Sales Reps, Ex-Firefighter Cop To NJ Prescription Fraud
• HHS Must Justify 'Turbocharged' Hospital Data, DC Circ. Says
• Surgery Supply Cos. Slam Bid For Cert in Antitrust Suit
• Weingarten Applies Only To Mandatory Meetings: DC Circ.
• Care Managers Not Supervisors, Split NLRB Affirms
• Mich. Doctor Charged With Prescribing Unnecessary Opioids
• Pa. Pharmacy Must Face Horizon's Fraud Suit, Judge Says
• Consultant Not Liable To Nursing Home Workers: 6th Circ.
• Par Pharmaceutical Beats FCA Prescription-Switch Claims
• Houston Clinic Owner Gets 40 Years For $17M Medicaid Fraud
• Drugmaker Moves To Stop Natal Vitamin Reclassification
• 5 Tips For A Successful Legal Blog
• 2 Plead Guilty To $25M NJ Prescription Fraud Scheme
• OMB Lays Out R&D Priorities For 2019 Agency Spending
• Former FTC Litigator Joins Constantine's Antitrust Practice
• Pa. AG Appeals False Ad Suit Against Nursing Home Chain
• Acadia Shareholders, Execs Slash Stakes In Health Care Co.
• Troutman Sanders Must Exit FCA Suit, Says Health Care Co.
• Fed. Circ. Affirms PTAB Nix Of Root Canal Patent As Obvious
• 'Unhinged' Insider Trading Defendant Pesters Feds Again
• Lateral Surge On The Horizon As BigLaw Gets Into Pot
• Maintaining The Integrity Of Physician-Owned Practices
• Funeral Home Owner Can't Bury Tax Conviction At 4th Circ.
• Aetna Wins Stay In ACA Withdrawal Suit For Internal Probe
• Sanofi Blew Whistle On Mylan's EpiPen Rebate Woes: Feds
• J&J, Woman Spar Over Science At Cancer Trial's Close
• Tenn. Court Backs Whistleblower's Win Against Nursing Home
• Sen. Harris Beats Claim She Was Bribed To Block Health Deal
• 10th Circ. Ruling Backs Tribal Court In Opioid Suit: Cherokees
• Trump To Extend ACA Subsidies After CBO Warning
• EB-5 Investor Not Worried About Atty Trading With His Cash
• LA Hospital Appeals Order To Release Rate Info In BCBS MDL
• 8th Circ. Won't Shield Planned Parenthood Medicaid Pay
• Del. Rehab Center Loses Bid To Shift Suit To Arbitration
• Judging A Book: Kopf Reviews Posner's 'Federal Judiciary'
• Ares Injects $1.45B Into DuPage Medical Group
• Firing Needlephobic Pharmacist Violates ADA, Justices Told
• Trump Disbands Deteriorating CEO Advisory Councils
• Hemophilia Groups Accuse Iowa Blue Cross Affiliate Of Bias
• FDA Warning Wire: Another Co. Blasted For Belladonna
• Talc-Cancer Link Is Weak, J&J Expert Says At Trial's End
• Judge Rejects Theranos Investors' Bid To Pause Settlements
• Polsinelli Picks Up Texas-Based Bankruptcy Shareholder
• Highmark Must Face Antitrust Suit Over Insurance Rates
• Kaufman Dolowich Snags Ex-Fowler White Duo In Florida
• Trump's ACA Threat Would Send Insurers Fleeing, CBO Says
• DC Circ. Clears DEA To Block Supplier From Selling Opioids
• Summit Healthcare Drops $60M For Stake In 9 Properties
• What Providers Need To Know About NJ's Telemedicine Law
• The Use Of Special Masters In Complex Cases
• 2nd Circ. Lowers Bar For Employee FMLA Retaliation Claims
• A Plaintiff's Guide To Discovery Proportionality: Part 2
• Notes From A Law Firm Chief Privacy Officer
• Ill. Appellate Court Backs Doctor's Suspension In Rx Case
• Fetal Tissue Researchers Must Prove Privacy Need: 9th Circ.
• No Sign J&J Talc Caused Woman's Cancer, Doc Tells Jury
• Ex-CFO Tells 2nd Circ. Jury Needed To Know Witness's Affair
• Talk Of Deal As Women Ask 2nd Circ. To Revive Mirena MDL
• EEOC Says Walter Reed Staffing Co. Fired Pregnant Worker
• Doctor Can't Escape $550M Social Security Fraud Verdict
• Trump Signs $2.1B Extension Bill For VA Choice Program
• Texas AG Asked If Federal Law Nixes Health Insurance Rule
• US Defends Bid To Quash Menendez Subpoenas
• CVS, Walgreens Press Bid To Block Cherokee Opioid Suit
• A Plaintiff's Guide To Discovery Proportionality: Part 1
• Notes From A Law Firm Chief Privacy Officer: New Demands
• Medical Practice Seeks Quick Win In Allscripts TCPA Suit
• Why UnitedHealthcare's Litigation Against CMS Is Unique
• Abortion Foe Wants High Court To Strike Down Video Ban
• News Outlets Ask Shkreli Trial Judge For Juror Names
• Taxation With Representation: Simpson, Sidley, Sullivan
• Insurer Needn't Cover Ex-Patients Who Set Fire In Building
• Talc No Cancer Risk, Ex-FDA Scientist Tells J&J Jury
• DaVita Investors Move To Consolidate Derivative Suits
• Escobar's FCA Test Is Mandatory, Judge Rules
• Health Hires: CMS Officials Move On To BCBS, PatientPing
• Split 7th Circ. OKs Forum Choice Clauses In ERISA Plans
• Attys File Dueling Motions For Class Cert. Against Aetna
• Escobar Provides New Grounds For Seeking Gov't Discovery
• BioScrip Urges Del. Justices Not To Revive Shareholder Suit
• After Trial Error, Medicare And Visa Fraudster Gets Probation
• Patients Can Be Considered Victims In Insys Bribery Case
• Judge Erred On Medicare Appeals Backlog, DC Circ. Rules
• 9th Circ. Won't Let Medical Staff Intervene In FCA Case
• What To Know About New FDA Informed Consent Guidance
• It's Time To Improve Voir Dire In Federal Court
• Notes From A Law Firm Chief Privacy Officer: Insider Risks
• Woman Says Cancer A Surprise After Years Of J&J Talc Use
• Kaiser Faces Uphill Battle To Nix Generic Drug Cost Suit
• Eye Doc Tied To Sen. Menendez Gets Sentencing Postponed
• Trump To Declare Opioid Crisis A National Emergency
• Secretary Says Ex-DC Director's Days At VA Numbered
• FDA Says Fla. Pharmacy Is Not Properly Sterilizing Equipment
• 5 Deaths Linked To Obesity Stomach Balloons, FDA Warns
• NJ Nurse Accused Of Sexual Assault Gets License Suspended
• Trans Military Ban Would Spend $1B To Save $8M, Study Says
• Sexual Health Chain Peekay Plans Sale In Del. Ch. 11
• 5th Circ. Panel Rules In Favor Of Mandatory Class Waiver
• Real Estate Atty Next To Helm Polsinelli Eyeing Health Care
• Notes From A Law Firm Chief Privacy Officer: Balancing Act
• 8 Years Of Health Care Enforcement: Doing Less With More
• Litigation Funding Boosts Med Mal Payouts, New Study Says
• WebMD Hit With Shareholder Suit Over $2.8B KKR Buyout
• Pa. Court Orders New Trial In Nursing Home Suit
• CVS, Walgreens Hit With Class Actions Over Rx Clawbacks
• PE-Backed Cotiviti Unveils $370M Secondary Offering
• What Attys Need To Know About Trump's Opioid Policies
• Watchdog Says VHA Improperly Bills For Service Conditions
• Doctor At Heart Of $374M Medicare Fraud Gets 35 Years
• Humana Beats NJ Specialty Pharmacy's Antitrust Suit
• ITC Will Probe Hemophilia B Med Patent Infringement Claims
• ACLU Sues DC Metro Over Rejected 1st Amendment Ads
• CMS Insider Trading Cooperator Settles Case With SEC
• Menendez's Dismissal Bid Over McDonnell Must Await Trial
• Express Scripts Dodges Suit Claiming It Stole Clients
• How The IPad Can Be A Litigator's Best Friend
• Notes From A Law Firm Chief Privacy Officer: CPO Vs. CISO
• Studies Showing No Talc-Cancer Link Are Flawed, Jury Hears
• Pa. Court Tosses Doc's Defamation Suit Against Assistant
• Pa. Trans Students Settle 'Assigned' Bathroom Rule Suit
• Texas Tells 5th Circ. Planned Parenthood Medicaid Cutoff OK
• Del. Medical Board Sanction Overturned In 'Ugly' Case
• PBGC, Creditors Object To Hospital Laundry Co.'s Ch. 11 Plan
• FDA Warning Wire: NYC Embryo Co., Feline Peanut Protector
• 9th Circ. Nixes HHS Approval Of Calif. Medicaid Rate Cut
• Fake Ariz. Doctor Gets 38 Years For Botched Liposuctions
• Hospital Says 21st Century Ch. 11 Can't Shield Affiliate
• Damaged Drug Claims Unsupported, CVS Unit Says
• Real Estate Rumors: MetLife, Midtown Capital, Yelp
• CIA Interrogation Plan Authors Can't Escape Torture Suit
• Hospital Must Face EEOC Suit Over Flu Vaccines Requirement
• Root Canal Patent Not Obvious, Fed. Circ. Hears
• Envision Inks $2.4B Ambulance Biz Sale To KKR-Backed Co.
• Making Good Better: How To Improve Medicare Part D
• Industrial Talc Litigation: New Mass Tort Or False Alarm?
• 5 Questions To Ask Before Entering Joint-Representation AFA
• Partisan Tax, Health Bills Still Most Likely Outcome
• Shkreli's Brazen Defiance May Lead To Harsher Sentence
• Fla. Doctor Gets 6 Years For Using Foreign, Unlicensed Drugs
• CareCentrix Can't Survey Putative Data Breach Class Members
• FDA Says Death Linked To Turmeric IV Product
• K&L Gates Hires Former Sen. Murkowski Staffer As Partner
• Gov't Urges Quash Of Menendez Subpoenas On Agencies
• 1-800 Contacts Says Competition Claims Time-Barred
• Judge Urged To Stay Aetna ACA Withdrawal Suit For Inquiry
• Fresenius To Buy Home Dialysis Firm NxStage For $2B
• Legal Incubators Can Help New Lawyers And Society
• VA Facility Failed To Diagnose Nerve Swelling, Suit Says
• Texas AG, Dental Supply Co. Settle Antitrust Claims
• A Place For Mom Hit With TCPA Class Action
• Another Nursing Home Suit Sent To Arbitration Post-Kindred
• Molina Healthcare Wins $52M In ACA Risk Corridor Dispute
• Talc Use Causes Ovarian Cancer, Calif. Jury Told
• How The ACA Survived A 7-Year War
• 3rd Circ. Won't Exempt Secular Group From ACA Mandate
• Envision Hit With Stock-Drop Suit After NYT Article
• Hospital Co. Overlooked Doc's Sexual Assaults, Patients Say
• NJ Hospital, Nurses Ask Court To Bless $40M ERISA Deal
• Medicare Advantage Groups Push To Keep State Farm Suit
• Taxation With Representation: Debevoise, Weil, Davis, Hogan
• Shkreli Convicted On 3 Counts In Securities Fraud Trial
• VA Doctor Not At Fault For Patient Suicide, Report Finds
• No-Show NYC Pharmacy Loses TCPA Junk Fax Class Action
• The Growing Circuit Split Over FCA First-To-File Rule
• Breaking Down Graham-Cassidy ACA-Replacement Proposal
• Data Breach Suits Find Easier Path With DC Circ. Ruling
• Insys To Settle Opioid Lawsuit With Illinois For $4.5M
• Menendez Fights Again To Nix Charges Based On McDonnell
• Texas Atty Pleads Guilty To $27M Workers' Comp Fraud
• Fed. Gov't Can't Trim $12M Wrongful Birth Award
• Insurer Can't Nix Coverage After Defending Suit, Court Told
• Senate Confirms Flood Of Trump Nominees
• JPML Sends Acid-Reflux Drug Litigation To New Jersey
• Feds Join False Claims Suit Against Ambulance Co.
• Congress Passes FDA Reauthorization, Approval Reforms
• Rising Star: Crowell & Moring's Michael Lieberman
• Trump's HHS Attorney Pick Vows Neutrality On ACA
• Philips Nets Just $7.1M In Defibrillator Infringement Case
• Software IP — It's Not Just For Tech Cos. Anymore
• Va. Court Must Decide If Trans Bathroom Suit Is Moot: 4th Circ.
• 2nd Circ. Affirms Icahn Win Over Short-Swing Trading Suit
• How To Prioritize Your Law Firm's Crisis Response Plan
• Rising Star: Manatt Phelps' Michael Kolber
• Ex-Harvard Doc Tells Jury Woman's Ovaries Contained Talc
• Perrigo Gets A Mulligan On $10M IP Verdict Appeal
• Feds Defend Eye Doc Presentence Report In Medicare Fraud
• Woman Can't Show Eye Clinic Firing Was Pretextual: 3rd Circ.
• DOJ Ramps Up Fight Against Opioid Fraud With 12-Atty Unit
• Senate Passes $2.1B Extension To Veterans Choice Fund
• Atty Tried To Pass Off EB-5 Investor Cash As Own: Lender
• A Glimpse Into DOJ's New Health Care Enforcement Initiative
• Kansas Nonprofit Says It's Not A 'Corporation' In IRS Fight
• Accommodating Medical Marijuana Users: A National Trend?
• Innovating For Wise Juries: Closing Argument
• FDA Tobacco Policy Shift Will Be Years In The Making
• 17 States Can Join Big ACA Subsidies Case, DC Circ. Rules
• Texas Fraudsters Can't Slip $374M Medicare Scam Convictions
• Lawyer Misused EB-5 Investor Money, Court Told
• Theranos, Walgreens Settle $140M Contract Suit
• Private Opioid Scripts Pose Risk To VA Patients, OIG Warns
• Express Scripts Ducks Stockholder Suit Over Anthem Dispute
• CVS Can't Duck State Dilution Claim In Heart Trademark Suit
• Feds Need Not Subsidize ACA Risk Corridors, Judge Rules
• Bostwick Ch. 11 Moves Ahead After Insider Suit Compromise
• Senate Panel To Work On Short-Term Health Care Fixes
• Calif. Panel Says Nursing Home Suit Belongs In Arbitration
• Shkreli Jury Asks Judge About 'Fraudulent Intent'
• DC Circ. Says CareFirst Breach Suit Holds Up Under Spokeo
• Express Scripts Will Favor Mylan's EpiPen Over Competitors
• Rising Star: Hausfeld's Gary Smith
• Patent Co. Asks Fed. Circ. To Revive Hip Implant Patent
• Insurer Fights Covering Negligence Claims In Med Mal Suit
• Medical Co. Owner Charged With Diverting Investor Funds
• What's Next For ACA Repeal?
• The Soft Power Of Congress To Challenge Mergers
• 5 Questions All AFAs Should Answer Clearly